By Counterforce Health Team in Defitelio (defibrotide) —

Get Defitelio (Defibrotide) Covered by UnitedHealthcare in Georgia: Decision Tree & Appeal Guide

Answer Box: Quick Path to Defitelio Coverage

Do you qualify for Defitelio (defibrotide) coverage by UnitedHealthcare in Georgia? If you have hepatic veno-occlusive disease (VOD) with renal or pulmonary dysfunction after stem cell transplant, likely yes—but prior authorization is required. Fastest path: 1) Confirm diagnosis meets FDA criteria, 2) Submit comprehensive PA request through OptumRx with complete clinical documentation, 3) If denied, file internal appeal within 180 days. Georgia residents get external review rights through the Department of Insurance within 60 days of final denial.

Table of Contents

  1. How to Use This Decision Tree
  2. Eligibility Triage: Do You Qualify?
  3. If "Likely Eligible": Document Checklist
  4. If "Possibly Eligible": Tests to Request
  5. If "Not Yet": Alternatives and Exception Requests
  6. If Denied: Appeal Path Chooser
  7. Coverage Requirements at a Glance
  8. Common Denial Reasons & How to Fix Them
  9. Georgia-Specific Appeal Rights
  10. Costs & Patient Assistance
  11. FAQ
  12. Sources & Further Reading

How to Use This Decision Tree

This guide helps patients and clinicians navigate UnitedHealthcare's prior authorization (PA) process for Defitelio (defibrotide) in Georgia. UnitedHealthcare requires PA for Defitelio through OptumRx, their pharmacy benefit manager.

Start here: Answer the eligibility questions below to determine your approval likelihood. Then follow the corresponding action path. If denied, use Georgia's external review process for a second opinion from independent medical experts.

Note: This is educational information, not medical advice. Always consult your healthcare team and verify current policy details with UnitedHealthcare.

Eligibility Triage: Do You Qualify?

✅ Likely Eligible if ALL apply:

  • Diagnosed with hepatic VOD/SOS after hematopoietic stem cell transplant (HSCT)
  • Evidence of renal OR pulmonary dysfunction
  • Treatment planned within 60 days post-HSCT
  • No active severe bleeding or contraindications
  • Hospital/infusion center administration available

⚠️ Possibly Eligible if SOME apply:

  • VOD/SOS diagnosis but unclear organ dysfunction
  • Prophylactic use in high-risk patient
  • Outside typical post-HSCT timeframe
  • Coagulopathy concerns but manageable

❌ Not Yet Eligible if:

  • No confirmed VOD/SOS diagnosis
  • No prior HSCT
  • Active severe bleeding
  • Seeking off-label use without strong evidence

If "Likely Eligible": Document Checklist

Your prescriber needs these documents for PA submission:

Clinical Documentation Required:

  • VOD/SOS diagnosis confirmation with clinical criteria (weight gain >5%, hepatomegaly, ascites, jaundice)
  • Post-HSCT status with conditioning regimen details
  • Organ dysfunction evidence:
    • Renal: Creatinine elevation, fluid retention
    • Pulmonary: Dyspnea, pleural effusion, oxygen requirement
  • ICD-10 code: K76.5 (hepatic veno-occlusive disease)
  • Dosing plan: 6.25 mg/kg IV every 6 hours per FDA labeling

Submission Path:

  1. Provider submits PA through OptumRx portal or fax
  2. Standard review: 72 hours for decision
  3. Expedited review: 24 hours if medically urgent
  4. Required forms: Use OptumRx PA form (verify current version on provider portal)

If "Possibly Eligible": Tests to Request

Work with your transplant team to gather additional evidence:

Diagnostic Tests to Consider:

  • Doppler ultrasound to assess hepatic blood flow
  • CT/MRI abdomen for hepatomegaly, ascites quantification
  • Pulmonary function tests if respiratory symptoms
  • Comprehensive metabolic panel for renal function trends

Timeline to Re-apply:

  • Gather results within 1-2 weeks
  • Resubmit PA with strengthened clinical picture
  • Consider peer-to-peer review with UnitedHealthcare medical director

If "Not Yet": Alternatives and Exception Requests

Alternative Approaches:

  • Supportive care per transplant center protocols
  • Fluid management and diuretics
  • Dialysis for severe renal dysfunction

Exception Request Strategy:

  • Document why standard alternatives are inadequate
  • Provide literature supporting off-label use
  • Include transplant specialist's medical necessity letter
  • Consider Counterforce Health's evidence-backed appeal assistance

If Denied: Appeal Path Chooser

Level 1: Internal Appeal

  • Deadline: 180 days from denial date
  • How to file: UnitedHealthcare member portal or mail
  • Required: Denial letter, medical records, physician letter
  • Timeline: 30 days for standard, 72 hours for urgent

Level 2: Peer-to-Peer Review

  • When to use: Complex clinical cases needing specialist input
  • How to request: Call number on denial letter
  • Who participates: Your prescriber + UnitedHealthcare medical director
  • Timeline: Usually scheduled within 3 business days

Level 3: Georgia External Review

  • Eligibility: After exhausting internal appeals
  • Deadline: 60 days from final denial
  • Cost: Free to consumer
  • How to file: Georgia Department of Insurance
  • Timeline: 45 days standard, 72 hours expedited

Coverage Requirements at a Glance

Requirement Details Source
Prior Authorization Required through OptumRx UHC Formulary
Diagnosis Hepatic VOD/SOS post-HSCT FDA Label
Organ Dysfunction Renal OR pulmonary required Blue Shield Policy
Administration Hospital/infusion center only FDA Label
Duration Up to 60 days post-HSCT FDA Label
Appeal Deadline 180 days internal, 60 days external GA DOI Rules

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn
"Not medically necessary" Submit detailed medical necessity letter citing FDA approval and clinical guidelines
"Lacks organ dysfunction" Provide lab values, imaging showing renal/pulmonary involvement
"Off-label use" Include peer-reviewed literature and transplant specialist rationale
"Site of care restriction" Confirm hospital/infusion center administration plan
"Missing documentation" Resubmit with complete clinical package and HSCT history

Georgia-Specific Appeal Rights

Georgia residents have strong consumer protections for insurance appeals:

Key Rights:

  • External review conducted by independent physicians
  • No cost to consumer for external review
  • Binding decision on UnitedHealthcare
  • 60-day deadline from final internal denial
  • Expedited review available for urgent medical needs

Getting Help:

  • Georgians for a Healthy Future: 404-567-5016, healthyfuturega.org
  • GA DOI Consumer Services: 1-800-656-2298
  • Legal aid referrals available through consumer advocacy groups

When navigating complex insurance denials, Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters and plan policies to draft point-by-point rebuttals aligned with payer-specific requirements.

Costs & Patient Assistance

Manufacturer Support:

  • Jazz Pharmaceuticals patient assistance programs
  • Hospital financial counselors for buy-and-bill arrangements
  • Copay assistance may be available (verify eligibility)

Foundation Resources:

  • National transplant-focused foundations
  • State pharmaceutical assistance programs
  • Hospital charity care policies

FAQ

Q: How long does UnitedHealthcare PA take for Defitelio in Georgia? A: Standard review is 72 hours; expedited review is 24 hours if medically urgent.

Q: What if Defitelio is non-formulary on my plan? A: Request a formulary exception with medical necessity documentation showing no suitable alternatives.

Q: Can I request an expedited appeal in Georgia? A: Yes, both internal appeals and external reviews can be expedited if delay would seriously jeopardize health.

Q: Does step therapy apply to Defitelio? A: Generally no, as it's a specialized orphan drug for a specific post-transplant complication with no direct alternatives.

Q: What happens if my external review is approved? A: UnitedHealthcare must cover the treatment—the decision is legally binding on the insurer.

Q: Who can help me navigate the appeal process? A: Georgians for a Healthy Future provides consumer assistance, and Counterforce Health offers specialized appeal support for complex drug denials.

Sources & Further Reading

Disclaimer: This information is for educational purposes and does not constitute medical or legal advice. Insurance policies and state regulations change frequently. Always verify current requirements with your insurer and consult healthcare professionals for medical decisions. For personalized assistance with insurance appeals, consider consulting with patient advocacy organizations or specialized services like Counterforce Health.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.